CBD News

What you need to know (and what we are working to understand) about products containing cannabis or cannabis-derived compounds, including CBD

Some CBD products are marketed with unproven medical claims and can be manufactured with hazardous manufacturing practices.

Unlike FDA-approved CBD medicinal products, unapproved CBD products, which may include cosmetics, foods, products sold as dietary supplements, and any other product (other than Epidiolex) that has therapeutic claims, have not been evaluated. The FDA on whether they are effective in treating a particular disease or have other claimed effects. In addition, they have not been evaluated by the FDA to determine the correct dosage, how they might interact with other drugs or foods, or whether they have dangerous side effects or other safety concerns.

Misleading, unproven, or false claims about CBD products can cause consumers to delay receiving important medical care, such as proper diagnosis, treatment, and supportive care. For this reason, it is important to talk to your doctor about the best way to treat diseases or conditions with FDA-approved treatment options available.

In addition to safety risks and unproven claims, the quality of many CBD products may also be in question. The FDA is also concerned that the lack of appropriate controls and processing practices could put users at additional risk. For example, the agency has tested the chemical content of cannabinoid compounds in some of the products and found that many of them do not contain the CBD levels they claim. We are also investigating reports of CBD potentially containing hazardous levels of pollutants (eg pesticides, heavy metals, THC).

CBD products are also available for pets and other animals. The FDA has not approved CBD for any use in animals, and concerns about CBD products with unproven medical claims and of unknown quality also apply to CBD products available on the animal market. The FDA recommends that pet owners talk to their veterinarians about appropriate treatment options for their pets.

The FDA’s top priority is to protect public health. This priority includes ensuring that consumers are aware of products that put their health and safety at greatest risk, such as those that claim to prevent, diagnose, treat, alleviate or treat serious diseases. For example, the agency has warned companies to stop selling CBD products that they claim are designed to prevent, diagnose, treat, alleviate or cure serious diseases such as cancer, Alzheimer’s disease, psychiatric disorders and diabetes. Although we have focused on these types of products, we will continue to monitor the market for any product that poses a risk to public health, including those with hazardous pollutants, those marketed to vulnerable populations, and products that otherwise expose public health at risk.

Source link

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button